SUBSCRIBE
SUBSCRIBE

Biogen

NEWS
Genetown
Biogen Idec, Inc. (Massachusetts) Hopes To Have PML-Related Test By Year-End
March 26, 2009
 · 
1 min read
Drug Development
Genentech, Inc. and Biogen Idec, Inc. (Massachusetts) Rituxan May Heal Common Kidney Condition
August 7, 2008
 · 
1 min read
Policy
Carl Icahn Says Biogen Idec, Inc. (Massachusetts) Documents From Failed Sale Process Contain ‘Untruths’
June 5, 2008
 · 
1 min read
Biotech Bay
Desperate But Not Crazy
April 1, 2008
 · 
2 min read
BioCapital
FDA Warns of Tysabri Liver Risk; Biogen Idec, Inc. (Massachusetts) and Elan Corporation PLC Slide on Woes
February 28, 2008
 · 
1 min read
Ringing in the New Year
January 31, 2008
 · 
5 min read
Genetown
BB Biotech AG Invested 9.5% of its Portfolio in Biogen Idec, Inc. (Massachusetts)
October 16, 2007
 · 
1 min read
Job Trends
Beantown/Genetown and Beyond: Biotechnology in Massachusetts
September 13, 2007
 · 
11 min read
Drug Development
No New Brain Infection Cases with MS Drug Biogen Idec, Inc. (Massachusetts)'s Tysabri
August 28, 2007
 · 
1 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
JOBS
IN THE PRESS
Press Releases
Ionis completes enrollment in pivotal cohort of the Phase 3 REVEAL study evaluating obudanersen in Angelman syndrome
July 6, 2026
 · 
6 min read
Press Releases
Samsung Bioepis Relaunches BYOOVIZ® (ranibizumab-nuna) in the United States in Partnership with Harrow
July 1, 2026
 · 
8 min read
Press Releases
Biogen to Highlight Breadth of Alzheimer’s Disease Portfolio at AAIC 2026, Including Phase 2 CELIA Data for Diranersen
June 29, 2026
 · 
13 min read
Press Releases
Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc.
June 18, 2026
 · 
8 min read
Press Releases
New Progress Toward Public Reimbursement of SKYCLARYS™ for People Living with Friedreich Ataxia in Quebec
June 8, 2026
 · 
4 min read
Press Releases
FNIH Names Recipients of the 2026 Charles A. Sanders, MD, Partnership Award
June 4, 2026
 · 
3 min read
Press Releases
Biogen’s Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy
June 4, 2026
 · 
13 min read
Press Releases
EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus
June 4, 2026
 · 
18 min read
Press Releases
Biogen Announces Upcoming Kidney Presentations at European Renal Association and American Transplant Congresses
June 3, 2026
 · 
20 min read
Press Releases
UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus
June 1, 2026
 · 
16 min read
Load More